Publications 2001

 

Paediatric European Network for Treatment of AIDS (PENTA). Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial. Arch Dis Child 2001, 84 : 230-236.Lien PubMed

Toneatti C, Debled P, Cassard S.Financial contracts between sponsors and investigators. Applied Clinical Trials avril 2001 : 64-68.


Pialoux G, Gahéry-Ségard H, Sermet S, Poncelet H, Fournier S, Gérard L, Tartar A, Gras-Masse H, Levy JP, Guillet JG.Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. AIDS 2001, 15 : 1239-49.Lien PubMed

Scott-Algara D, Aboulker JP, Durier C, Badell E, Marcellin F, Prud'homme M, Jouanne C, Meiffredy V, Brun-Vézinet F, Pialoux G, Raffi F.CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.
Clin Exp Immunol 2001, 126 : 295-303.Lien PubMed

Delta Co-ordinating Committee of the Delta Trial.Evidence for prolonged clinical benefit from initial combination antiretroviral therapy.
HIV Med 2001, 2 : 181-188. Lien PubMed

Abgrall S, Charreau I, Joly V, Bloch J, Reynes J.Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues.
Eur J Clin Microbiol Infect Dis 2001, 20 : 346-349. Lien PubMed

Gougeon ML, Rouzioux C, Liberman I, Burgard M, Taoufik Y, Viard JP, Bouchenafa K, Capitant C, Delfraissy JF.Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients.
AIDS 2001, 15 : 1729-1731.Lien PubMed

Rabaud CH, Charreau I, Izard S, Raffi F, Meiffredy V, Leport C, Guillemin F, Yeni P, Aboulker JP. Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent disease progression.
Scand J Infect Dis 2001, 33 : 759-764.Lien PubMed